vimarsana.com

Page 8 - டைவாந் தொழில்நுட்பம் அரங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NIPPON SHOKUBAI: Enhancement of Facilities and Patent Rights for Lithium-ion Battery Electrolyte IONEL (LiFSI)

NIPPON SHOKUBAI: Enhancement of Facilities and Patent Rights for Lithium-ion Battery Electrolyte IONEL (LiFSI) NIPPON SHOKUBAI: Enhancement of Facilities and Patent Rights for Lithium-ion Battery Electrolyte IONEL (LiFSI) NIPPON SHOKUBAI CO., LTD. (TOKYO:4114) (https://www.shokubai.co.jp/en/) has decided to begin facility design of new electrolytes “IONEL TM – Lithium bis(fluorosulfonyl) imide [LiFSI]” for lithium-ion batteries by setting up the “IONEL Construction Team” on October 1, 2020 in order to construct new manufacturing facilities (annual production capacity: 2,000 tons; location: Ichikawa, Chiba) using its own process. The decision is made because current production capacity, the annual production capacity of 300 ton, is insufficient for the increasing demand. Commercial production by the new facility will start from spring 2023.

CES 2021 Uniigym Combines AI and Cloud Algorithms to Change Virtual Fitness Apps

CES 2021 Taiwanese startup FiduciaEdge Technologies develops Edge security solution for a secure edge computing environment

Covid update: 14 January 2021

14 Jan 2021 A round-up of this week s coronavirus-related news and countermeasures from the photonics industry. Digipredict digital twin is designed to predict the evolution of Covid-19.Under a cross-disciplinary program spearheaded by the Swiss Federal Institute of Technology in Lausanne, scientists from MESA+, Twente, The Netherlands, among others, are developing an AI-based system to predict whether Covid-19 patients will develop severe cardiovascular complications. In the longer term these systems could detect the likely onset of inflammatory disease. EPFL has launched a pan-European research program called Digipredict. The goal is to develop a digital twin that can detect serious complications in Covid-19 patients, employing breakthrough technology in the fields of artificial intelligence, smart patches and organs-on-chips. The initiative brings together around a dozen partner organizations (universities, hospitals and startups).

VesCir poised to revolutionize skincare industry at CES 2021 with AI-driven iCi skincare system

Share this article Share this article TAIPEI, Jan. 12, 2021 /PRNewswire/ Taiwanese biotech startup, VesCir, inspired by Nasa s Skin.B project, will have a launch of its own this year at CES 2021, where it will showcase its medical grade portable dynamic skincare system; a first on the market. The future of skincare now; Dynamic Skincare VesCir has always been ahead of the curve. The team, led by Chen Weiyu - a biomedical science PhD, and space enthusiast, has been studying skin changes for several years, predicting that one of humanity s biggest challenges in the space age will be how we maintain healthy skin in space. NASA was also interested in the same question, establishing the Skin B project to examine the process of skin aging so they could better understand how to protect people s skin

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.